Pulmonary Fibrosis Stocks List

Pulmonary Fibrosis Stocks Recent News

Date Stock Title
Jul 9 MORF Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
Jul 9 MORF What Eli Lilly Is Getting With The Acquisition Of Morphic Holding
Jul 9 MORF Company News for July 9, 2024
Jul 9 MORF Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.
Jul 9 MORF S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
Jul 8 MORF US Equities Markets End Mixed as Investors Await Inflation Data
Jul 8 MORF Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Jul 8 MORF Stocks to Watch Monday: Boeing, Paramount, Intel, Corning
Jul 8 MORF Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal
Jul 8 MORF Biden, Boeing plea deal, French markets: Morning Brief
Jul 8 MORF Top Midday Stories: Boeing Reaches Settlement with DOJ Over Fatal 737 Max Crashes; Eli Lilly Acquires Morphic for $3.2 Billion; Paramount to Merge with Skydance
Jul 8 MORF Eli Lilly Snaps Up Morphic For $3.2 Billion; Morphic Stock Hits The Stratosphere
Jul 8 MORF Eli Lilly to acquire Morphic in $3.2B deal
Jul 8 MORF Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly Doubles.
Jul 8 MORF Biggest stock movers today: LCID, PARA, GRFS, and more
Jul 8 MORF Eli Lilly Buys Morphic for $3.2B
Jul 8 MORF Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Jul 8 MORF Lilly to buy Morphic in $3B bet on inflammation drug
Jul 8 MORF Eli Lilly to Buy Morphic Holding for $3.2 Billion
Jul 8 MORF Lilly agrees to buy US biotech Morphic in $3.2 billion deal
Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.

Browse All Tags